Intervention Protocol

Vaccines for preventing cutaneous leishmaniasis

  1. Narges Khanjani1,*,
  2. Urbà González 2,
  3. Jo Leonardi-Bee3,
  4. Mehdi Mohebali4,
  5. Mehri Saffari5,
  6. Ali Khamesipour6

Editorial Group: Cochrane Skin Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD007634


How to Cite

Khanjani N, González U, Leonardi-Bee J, Mohebali M, Saffari M, Khamesipour A. Vaccines for preventing cutaneous leishmaniasis (Protocol). Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD007634. DOI: 10.1002/14651858.CD007634.

Author Information

  1. 1

    Kerman Medical University (KMU), Unit of Epidemiology & Biostatistics,Faculty of Public Health, Kerman, Iran

  2. 2

    Hospital Plató, Department of Dermatology, Research Unit for Evidence-based Dermatology, Barcelona, Catalunya, Spain

  3. 3

    The University of Nottingham, Division of Epidemiology and Public Health, Nottingham, UK

  4. 4

    Tehran University of Medical Sciences, School of Public Health, Tehran, Iran

  5. 5

    University of Shahid Bahonar, Kerman, College of Agriculture, Kerman, Iran

  6. 6

    Center for Research & Training in Skin Diseases & Leprosy, TUMS, Tehran, Iran

*Narges Khanjani, Unit of Epidemiology & Biostatistics,Faculty of Public Health, Kerman Medical University (KMU), Haft Bagh Blvd, Kerman, 76169-13555, Iran. n_khanjani@kmu.ac.ir.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate if vaccination with each of the different available vaccines reduces the occurrence of cutaneous leishmaniasis (CL) in endemic regions